Simone Gibertoni, CEO of Clinique La Prairie, shares insights on the brand’s 90-year legacy in longevity, the launch of their Longevity Fund, and the groundbreaking Dubai Longevity Hub, blending cutting-edge science, personalized therapies and wellness to redefine health and vitality.
Lifelong health isn’t just about adding years to your life, it’s about enhancing the quality of those years.
Having pioneered this field for 90 years, Clinique La Prairie (CLP) is at the forefront of this innovative revolution.
With their Longevity Fund and Dubai Longevity Hub, Clinique La Prairie redefines health and vitality through advanced diagnostics, personalized therapies and holistic wellness.
CLP’s pioneering efforts are creating ripple effects in the global wellness economy, whether it’s addressing cellular aging or boosting mental resilience.
Longevity is a key and rapidly growing component of the global wellness economy, which was valued at USD 5.6 trillion in 2022. The global longevity economy alone is projected to reach approximately USD 610 billion by 2025 (Global Wellness Summit 2024).
Simone Gibertoni, CEO of Clinique La Prairie, discusses the groundbreaking synergy between science, wellness and technology behind the Longevity Fund.
Clinique La Prairie has launched a Longevity Fund aimed at enhancing healthspan and lifespan innovations. Could you tell us more about the inspiration behind this initiative and its main objectives?
The launch of the Longevity Fund reflects Clinique La Prairie’s strategic commitment to driving forward the science and future of longevity – an area we have pioneered for over 90 years.
The fund is an initiative in collaboration with Prof. Stefan Catsicas and his seasoned team, structured to support projects and companies that drive innovation in next-generation health and wellness technologies, while providing investors with the opportunity to participate in a transformative shift within these industries.
CLP has recently expanded into Dubai with the Longevity Hub. What inspired this expansion, and how does it align with your global mission for health and longevity?
Expanding into Dubai with the Longevity Hub is a pivotal step in Clinique La Prairie’s strategy to bring its longevity expertise to new regions, allowing clients to integrate longevity practices into their daily lives, closer to home. It is the first of its kind, offering an exclusive approach. In the luxurious three-story setting of One & Only One Za’abeel, it provides ultra-personalized health journeys, beginning with unique Longevity Assessments. With pioneering therapies—from Senaptec brain & movement analysis and cryotherapy to IV drips and infrared detoxification —the Hub combines cutting-edge science with tailored solutions. Year-round membership programs offer comprehensive benefits for a truly transformative journey.
The Hub serves as a center for delivering CLP’s longevity approach to self-care and performance optimization, inside-out, with guidance from CLP experts.
The concept of longevity goes beyond just extending lifespan—it focuses on enhancing the quality of life. How does CLP’s approach differentiate itself in terms of integrating wellness, science, and advanced technology?
Yes, exactly, longevity means both, healthspan and lifespan. At Clinique La Prairie’s destinations, the goal is to help clients live fuller and healthier (this is our primary objective), and also to live longer. This speaks to the difference between healthspan and lifespan.
We do it by combining advanced diagnostics, cutting-edge treatments, and personalized therapies to address aging holistically. It’s what we call our CLP Longevity Method. Diagnostics are fundamental today because they not only allow us to anticipate (prevent) but also to tailor treatments. From simpler diagnostics like blood tests or X-rays to more complex ones—genetic, epigenetic, microbiota, glycans tests.
How does Clinique La Prairie’s Four Pillars approach—Medical, Nutrition, Wellbeing and Movement integrate advanced science and personalized therapies to optimize longevity and healthspan?
At Clinique La Prairie, we’ve divided this approach into what we call the Four Pillars: Medical, Nutrition, Wellbeing, and Movement. This structure helps clients understand the importance of a holistic approach to longevity, and also provides clear research categories for our team and an effective way to balance our programs. While all pillars are important, we place particular emphasis on the medical aspect.
The Nutrition Pillar includes 4-D advanced nutritional assessment, personalized nutrition therapy under CLP Method and longevity nutraceutical solutions. In the Wellbeing Pillar, we implement methodologies and technologies—some of which are exceptionally innovative—to reduce chronic stress and empower mental and cognitive health. Finally, in the Movement Pillar, we use the science of Sports Medicine to give a strong scientific angle with simple, personalized, and actionable protocols.
What are the Longevity Fund’s contributions to innovation in health care, nutrition, movement, and wellbeing?
As for the Longevity Fund itself, the structure also enables us to push boundaries over the long term. We align our investment strategy with four pillars: Medical Care, Nutrition, Movement, and Wellbeing. The fund supports entrepreneurs and researchers in these areas so they can develop innovative approaches to chronic inflammation, immune resilience, and cellular aging. New wellbeing ideas might focus on mental health and sleep quality; innovation in nutrition may focus on functional foods and AI-driven personalized nutrition; and movement innovations may focus on customizing exercise technologies.
By embracing this ecosystem vision, we are positioned to drive global advancements in longevity and healthcare.
Can you provide insights into the collaborative efforts or partnerships CLP has formed through its Longevity Fund to drive innovation?
We have formed a strategic partnership with Prof. Stefan Catsicas, one of the world’s foremost experts in longevity. Prof. Catsicas brings extensive experience in cell biology, having served as Professor and Chairman at the Lausanne School of Medicine and as Vice President of Research at the EPFL in Switzerland.
As a co-founder and advisor to several biotechnology firms and investment funds, Prof. Catsicas possesses a deep understanding of both biotechnology and large-scale investments. His role as Co-Chair of the Investment Committee and Investment Advisory at the Longevity Fund structure will leverage his expertise in advisory and investment strategy, making him an invaluable partner in shaping and guiding the fund’s strategic direction.
The primary goal of the fund is to accelerate innovation in longevity science by supporting projects that move beyond the exploratory research phase toward practical applications.
The Fund structure will focus on backing businesses that can bring scientifically-grounded, commercially viable solutions to market, for real-world impact. Our emphasis is on funding ventures that translate longevity research into tangible, scalable products and services that can improve human health and lifespan.
Looking forward, what are CLP’s plans for advancing the field of longevity science, how would you define the long-term vision for Clinique La Prairie in the context of global longevity and healthcare advancements?
In Clinique La Prairie’s long-term vision, innovation remains foundational. This commitment is supported by our in-house experts and by our collaborations with internationally renowned scientists on our Scientific Committee, who bring extensive insights on longevity and precision medicine, including areas like senescence, genetics, brain health, nutrigenomics, immunology, epigenetics, cell biology (just to name few), to consistently enhance our offerings.
In the future, we will develop further age-related diagnostics, nutrition approaches, or latest wellness technologies. Also, today, precision medicine is powered by predictive systems driven by AI and machine learning, allowing early detection of health shifts even in “silent mode.” By identifying subtle changes in the body, these systems enable targeted interventions to prevent disease progression and enhance longevity, empowering both doctors and patients. This transformative approach will continue shaping our method and offering.
